Articles Archives - Page 582 of 766

ThursdayDec 05, 2019 1:52 pm

Predictive Oncology Inc.’s (NASDAQ: POAI) TumorGenesis Tech Primed to Play Key Role in Cancer Drug Development Efforts

Predictive Oncology subsidiary TumorGenesis developing faster, less costly, and more accurate PDx cancer models that better mimic the patient's tumor TumorGenesis revolutionary technology will provide pharmaceuticals with quicker and more effective drug development while significantly improving patient outcomes There’s an unmet need for a multi-omic approach (genome, transcriptome, epigenome, proteome, responseome, and microbiome), but such data is difficult to generate quickly. Predictive Oncology has access to historical data that competitors need at least five years to develop, which presents a multi-million-dollar market opportunity The global cancer diagnostics market was valued at $144.4 billion in 2018 and is expected to grow…

ThursdayDec 05, 2019 12:52 pm

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces New VP to Lead Sales Operations

SPRWF welcomes new senior vice president of commercial to executive team Joel Toguri to advance and oversee company’s provincial, retail sales operations across all brands New VP has two decades of experience spanning the cannabis, alcohol beverage, and apparel industries The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a global diversified portfolio of cannabis companies, has announced the appointment of a new senior vice president of commercial (http://ibn.fm/2dtS0). With more than two decades of regulated industry expertise under his belt, including experience working in the cannabis space, Joel Toguri is well suited to further strengthening the SPRWF executive…

ThursdayDec 05, 2019 11:54 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Makes Edible Drug Delivery Platform Even Faster

Lexaria Bioscience is a company that is passionate about establishing alternatives to inhalation for rapid-response drug substance delivery in order to eliminate the lung harm that smoking or vaping may cause Lexaria’s DehydraTECH platform has generated numerous patents with more pending as a way to provide quick substance delivery to the user’s bloodstream and better access through the blood-brain barrier Lexaria recently announced it had further improved DehydraTECH, as demonstrated in testing that showed early pilot-stage human trial participants began to note edible THC effects in under 10 minutes – more rapidly than the previous DehydraTECH formulation Prior technology testing…

ThursdayDec 05, 2019 11:20 am

No Borders Inc. (NBDR) Develops, Releases Lab Test Recording Blockchain Platform

No Borders Inc. launches CBD LabChain blockchain platform aimed at testing market Global cannabis testing market projected to grow at CAGR of 13.2%, surpass $1.5 billion by 2026 NBDR announces $3 million Reg A offering qualification Laboratory CBD- and THC-concentration test results for retail CBD products are now on the blockchain, thanks to No Borders Inc. (OTC: NBDR). The company announced it had successfully developed and deployed a revolutionary platform for securely and immutably recording cannabinoid lab test data on its new blockchain based certification platform. The platform – CBD LabChain – was launched in November 2019 at Blockchain Expo…

WednesdayDec 04, 2019 2:17 pm

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Drug Delivery Platform Proven to Enhance Absorption of Bioactive Compounds

DehydraTECH™ is patent protected for multiple Active Pharmaceutical Ingredients (APIs) including hemp oil CBD and cannabis, nicotine, non-steroidal anti-inflammatory drugs, and fat-soluble vitamins Lexaria has 16 patents granted and over 60 patent applications pending worldwide DehydraTECH™ shown to facilitate rapid uptake and highly targeted delivery of pharmaceuticals to the brain Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, is accelerating its patented DehydraTECH based drug delivery technology and formulation development. Funding received from the first tranche of Lexaria’s previously announced private placement of units, issued at a price of $0.45 per unit, realized gross…

WednesdayDec 04, 2019 1:19 pm

No Borders Inc. (NBDR) Launches Revolutionary Blockchain-Based ‘CBD LabChain’ to Deliver Secure, Transparent and Verified Lab Results

CBD LabChain is the all new blockchain data security platform crafted to provide CBD brands with a transparent, immutable certification of CBD lab test results No Borders Labs believes CBD LabChain offers a powerful tool to overcome common consumer concerns regarding trying or using hemp-derived CBD products No Borders continues its early filing tradition as a listed company on the OTC Market, reporting another record quarter of revenue growth No Borders Inc. (OTC: NBDR), a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting edge technologies to reduce costs while increasing revenues…

WednesdayDec 04, 2019 12:47 pm

Dama Financial Product Integration With PayWana Set to Revolutionize Retail Checkout Processing

New Dama financial partnership with PayWana™ integrates online banking solution with self-service technology to minimize wait times and expenses at retail locations across U.S. The partnership is designed to uniquely address some of the challenges cash-intensive businesses face Holders of Premier accounts managed by Dama can send payments via electronic ACH, wire transfer, or check to approved payees on clients’ behalf Through a new strategic partnership, Dama Financial is integrating the online banking solution it manages on behalf of its sponsor banks, and its payment processing software Paytender(SM) with PayWana™ self-service technology, Dama Financial announced in a press release (http://ibn.fm/tg8xC). PayWana…

WednesdayDec 04, 2019 11:38 am

HTC Extraction Systems (TSX.V: HTC) Acquisition Augments Company’s Output Capability

HTC acquires California-based Kase Farma Inc. HTC Extraction Systems announces tolling contracts, project progress and more Hemp-derived CBD market set to grow to $22 billion by 2022 With the acquisition of a company engaged in the extraction, purification and wholesale distribution of hemp-based cannabinoid extracts, HTC Extraction Systems (TSX.V: HTC) has bolstered its output capability and institutional knowledge considerably. The acquired entity – Kase Farma Inc. of Ceres, California – is currently expanding and upgrading its extraction, refining and processing operations. Kase Farma will enter into an intellectual property licensing agreement with Starling Brands Inc., the vendor. Under this licensing…

WednesdayDec 04, 2019 11:14 am

Sigma Labs Inc. (NASDAQ: SGLB) Releases Q3 Numbers, Remains at the Forefront of Next Industrial Revolution

Company reports increased revenue over last year’s Q3 numbers Key operational highlights point to even stronger revenue growth moving into 2020 Sigma Labs’ pioneering software provides essential element to spur additive manufacturing into the next industrial revolution Sigma Labs Inc. (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D-printing industry, reported its financial and operational results for the third quarter ended Sept. 30, 2019 (http://ibn.fm/jmBVm). The company noted that recent progress with original equipment manufacturers (OEMs), end users and additive-manufacturing integrators positions SGLB for strong revenue growth in 2020. "The third quarter of 2019 was highlighted…

Site Search

Company Search

Category: Articles